Please wait while the formulary information is being retrieved.
VERKAZIA (cyclosporine)
- inflammation of cornea and conjunctiva in the spring
0.1 % eye drops in a dropperette
- Instill 1 drop into affected eye(s) by ophthalmic route 4 times per day
Default screening record
- Instill 1 drop into left eye by ophthalmic route 4 times per day
- Instill 1 drop into right eye by ophthalmic route 4 times per day
- Instill 1 drop into both eyes by ophthalmic route 4 times per day
- Instill 1 drop into affected eye(s) by ophthalmic route 4 times per day
- None
Contraindicated
- None
Severe
Moderate
- None
- Ocular infection
Contraindicated
- None
Severe
Moderate
- None
VERKAZIA (cyclosporine)
- inflammation of cornea and conjunctiva in the spring
- None
- Ocular irritation
- Ocular pain
More Frequent
Severe
Less Severe
- None
- Blurred vision
- Conjunctival hyperemia
- Eye tearing
- Ocular discharge
- Ocular redness
- Visual changes
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Bacterial keratitis
Less Severe
- Foreign body sensation of eye
- Ocular itching
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Cyclosporine (0.1% Ophth)
Safety and effectiveness not established age less than 4 years.
- 1 Day – 4 Years
- Safety and effectiveness not established age less than 4 years.
Cyclosporine (ophthalmic)
- Severity Level:
2
- Additional Notes: Systemic absorption not detected, fetal exposure not expected
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Cyclosporine (ophth)
Excretion in human milk after topical treatment has not been investigated
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Excretion in human milk after topical treatment has not been investigated |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Vernal keratoconjunctivitis | |
| H10.44 | Vernal conjunctivitis |
| H16.26 | Vernal keratoconjunctivitis, with limbar and corneal involvement |
| H16.261 | Vernal keratoconjunctivitis, with limbar and corneal involvement, right eye |
| H16.262 | Vernal keratoconjunctivitis, with limbar and corneal involvement, left eye |
| H16.263 | Vernal keratoconjunctivitis, with limbar and corneal involvement, bilateral |
| H16.269 | Vernal keratoconjunctivitis, with limbar and corneal involvement, unspecified eye |
| 0-9 | A-Z |
|---|---|
| H10.44 | Vernal conjunctivitis |
| H16.26 | Vernal keratoconjunctivitis, with limbar and corneal involvement |
| H16.261 | Vernal keratoconjunctivitis, with limbar and corneal involvement, right eye |
| H16.262 | Vernal keratoconjunctivitis, with limbar and corneal involvement, left eye |
| H16.263 | Vernal keratoconjunctivitis, with limbar and corneal involvement, bilateral |
| H16.269 | Vernal keratoconjunctivitis, with limbar and corneal involvement, unspecified eye |
Formulary Reference Tool